Expert Opinion on Pharmacotherapy

Chemotherapeutic management of malignant pleural effusion
pp. 1233-1242(10)
Authors: Weatherhead M.; Antunes G.

Delaying surgery with chemotherapy for osteosarcoma of the extremities
pp. 1243-1256(14)
Authors: Bielack S.S.; Machatschek J-N.; Flege S.; Jürgens H.

Pharmacological management of Ewing sarcoma family of tumours
pp. 1257-1270(14)
Author: Rodriguez-Galindo C.

Gallbladder cancer: current status
pp. 1271-1277(7)
Author: Malik I.A.

The role of -blockers in the management of prostate cancer
pp. 1279-1285(7)
Authors: Tahmatzopoulos A.; Rowland R.G.; Kyprianou N.

Management of pituitary apoplexy
pp. 1287-1298(12)
Authors: Chanson P.; Lepeintre J-F.; Ducreux D.

Pharmacological strategies in relieving neuropathic pain
pp. 1299-1312(14)
Author: McCleane G.

Pharmacological management of attention-deficit hyperactivity disorder
pp. 1313-1320(8)
Authors: Reeves G.; Schweitzer J.

A review of the proteasome inhibitor bortezomib in multiple myeloma
pp. 1321-1331(11)
Author: Richardson P.G.

Review of the immunosuppressant enteric-coated mycophenolate sodium
pp. 1333-1345(13)
Authors: Budde K.; Glander P.; Diekmann F.; Waiser J.; Fritsche L.; Dragun D.; Neumayer H-H.

Aceclofenac in the management of inflammatory pain
pp. 1347-1357(11)
Author: Legrand E.

Long-term oral carvedilol in chronic heart failure
pp. 1359-1372(14)
Authors: Di Lenarda A.; Sabbadini G.; Moretti M.; Sinagra G.

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy
pp. 1373-1384(12)
Author: Turpie A.G.

Extended-release niacin for modifying the lipoprotein profile
pp. 1385-1398(14)
Author: Guyton J.R.

Rivastigmine in vascular dementia
pp. 1399-1410(12)
Authors: Moretti R.; Torre P.; Antonello R.M.; Cazzato G.; Bava A.

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes
pp. 1411-1422(12)
Authors: Del Prato S.; Volpe L.

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials
pp. 1423-1430(8)
Authors: Salam A.M.; Al-Mousa E.N.

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery
pp. 1431-1434(4)
Author: Doggrell S.A.